From Anvita Health Wiki
More Specific Terms
Introduction
Indications
- all women > 65 years of age & all men > 70 years of age [1]
- USPSTF concludes not enough evidence to determine whether routine screening is beneficial or harmful for men [6]
Contraindications
- do not repeat in < 2-5 years unless patient is on long-term glucocorticoid therapy [1]
Clinical-significance
- bone mineral density ( BMD) increases with childhood growth & reaches a peak in the 3rd decade of life
- subsequently, a slow decline in BMD occurs
- a more acute loss in BMD occurs in women at the time of menopause
- BMD T-score <= -2.50 defines osteoporosis
- factors increasing bone mineral density
-
-
Methods
-
Interpretation
- Numerical scoring of BMD:
-
- measurements are imprecise: [5]
-
More General Terms
Additional Terms
References
- Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, American College of Physicians, Philadelphia 1998, 2006, 2009
- Iris Cantor - UCLA Women's Health Center Osteoporosis Evaluation
- Journal Watch 23(6):49, 2003 Elmstahl S et al Is there an association between inhaled corticosteroids and bone density in postmenopausal women? J Allergy Clin Immunol 111:91, 2003 PMID: [1]
- Fernandez-Garcia D et al Thin healthy women have a similar low bone mass to women with anorexia nervosa. Br J Nutr 2009 Mar 23; [e-pub ahead of print] <PubMed> PMID: [2] <Internet> [3]
- Bell KJL Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data BMJ 2009;338:b2266 [4]
- U.S. Preventive Services Task Force Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement Annals of Internal Medicine, January 17, 2011 <PubMed> PMID: [5] <Internet> [6]
- National Guideline Clearinghouse
- Osteoporosis and bone mineral density. American College of Radiology ngc-guideline: [7]
bone mineral density (BMD)